Silence Therapeutics plc
SLNCF
$0.95
$0.451490.53%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.82M | -74.64M | -49.93M | -43.32M | -53.33M |
| Total Depreciation and Amortization | 601.80K | 592.80K | 601.40K | 599.00K | 609.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.60M | 26.66M | 17.35M | 19.60M | 18.77M |
| Change in Net Operating Assets | -33.15M | -8.23M | -4.22M | -25.73M | -14.69M |
| Cash from Operations | -68.78M | -55.61M | -36.20M | -48.85M | -48.64M |
| Capital Expenditure | -214.10K | -148.30K | -109.80K | -21.50K | -54.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.80M | -87.33M | -23.72M | -30.40M | 19.29M |
| Cash from Investing | -24.01M | -87.48M | -23.83M | -30.42M | 19.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 36.80K | 20.90K | 20.90K | 83.90K | 35.90K |
| Issuance of Common Stock | 119.39M | 130.90M | 137.31M | 139.59M | 27.55M |
| Repurchase of Common Stock | -7.38M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.73M | -6.01M | -6.36M | -6.36M | 185.10K |
| Cash from Financing | 144.09M | 155.23M | 162.69M | 165.61M | 31.77M |
| Foreign Exchange rate Adjustments | -188.60K | -6.22M | 1.94M | 1.47M | 785.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.11M | 5.92M | 104.60M | 87.82M | 3.15M |